FDA expects to issue guidance on policies regarding generative AI devices, according to Rick Abramson, the agency’s head of ...
FTC challenges Amgen's Enbrel patent strategy, the long, winding path for the Moderna-Merck cancer vaccine, and more biotech ...
Pharmalittle: We’re reading about Medicaid obesity-drug coverage, a Regenxbio gene therapy, and more
President Trump’s pledge to make pricey weight loss drugs widely available for low-income Americans through Medicaid is not ...
The Food and Drug Administration has again paused trials for Regenxbio’s gene therapy for a rare childhood brain disorder, ...
New clues to RFK Jr.'s vaccine plans, a bottleneck for nurse practitioners, and more health news from Morning Rounds ...
This story about nurse practitioners was produced by The Hechinger Report, a nonprofit, independent news organization focused ...
The Trump administration plans to use a new approach to deny Medicaid coverage of drugs for gender-affirming care. The ...
Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — ...
New restrictions on the use of food benefits to purchase soda and candy have been one of the biggest changes enacted by the Make America Healthy Again movement. But a key question has been how ...
Isabella is a chronic disease reporter writing about how the Trump administration is tackling the nation’s health epidemic — or not. You can reach her on Signal at isabellacueto.03. The American ...
Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results